NICE recommends Incivo for hepatitis C

March 16, 2012
Sales and Marketing Incivo, Janssen, NICE, Victrelis, telaprevir

NICE is recommending Janssen’s hepatitis C pill Incivo for funding on the NHS in England. The drug has bypassed the …

meeting image

Meetings, bloody meetings

March 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Meetings, clinical trials

I read recently that less than 2% of NHS Trust board meeting agenda items require decisions. What happens during the …

GSK sells off OTC products

March 16, 2012
Sales and Marketing GSK, OTC, Omega Pharma, Zantac

GlaxoSmithKline has shed more of its non-core consumer health OTC products in a £391 million sale, including a German manufacturing …

Gilenya picture

NICE U-turn sees Gilenya MS pill recommended

March 16, 2012
Sales and Marketing MS, NICE, UK, fingolimod, gilenya

NICE has changed its mind on Novartis’ multiple sclerosis pill Gilenya, and is now recommending the drug in a subgroup …

Four new appointments at PAN Advertising

March 15, 2012
Medical Communications, Sales and Marketing Pan Advertising

PAN Advertising has made four new appointments since Jon Linscott took over as managing director in February, with two new …

GSK chooses Infosys and Fabric Worldwide for digital platform

March 15, 2012
Medical Communications, Sales and Marketing Fabric Worldwide, GSK, Infosys, digital

GlaxoSmithKline has hired two technology companies to help it optimise digital communications in consumer healthcare and pharmaceuticals.The firm will work …

Photodynamic treatment for HPV shows potential

March 15, 2012
Research and Development Cancer, GE Healthcare, HPV, Photocure, ipsen, oncologly

A new photodynamic therapy treatment for human papilloma virus (HPV) associated diseases of the cervix has shown potential in a …

Pradaxa image

NICE recommends Pradaxa for stroke prevention

March 15, 2012
Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation

NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …

Dismay as Sanofi announces UK plant closure

March 15, 2012
Manufacturing and Production, Sales and Marketing Plavix, Sanofi, job losses, manufacturing

Sanofi has decided to close down a manufacturing facility in the North East of the UK with the loss of …

Cmed release Global Strategic and Regulatory Consulting Booklet

March 14, 2012
Research and Development

The regulatory environments within the industry continue to change and vary internationally. Cmed’s regulatory and medical professionals keep track of …

Europe’s pharma sector : living through the crisis

March 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma

Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …

EMA begins pilot for electronic drug applications

March 14, 2012
Medical Communications EMA, European Medicines Agency, eCTD

The European Medicines Agency has launched a pilot scheme that allows pharma firms to submit new drug applications electronically.  The …

Maps and apps: video interviews with healthcare professionals

March 14, 2012
Medical Communications Digital Blog, apps

Last month the Department of Health released ideas for new apps aimed at patients and doctors. Below are some video …

Zytiga image

Charity attacks Scottish decision on Zytiga

March 14, 2012
Sales and Marketing Janssen, NICE, PAS, Prostate Cancer Charity, Zytiga

Scotland’s medicines regulator has turned down Janssen’s prostate cancer pill Zytiga, leading to a backlash from charities. The Scottish Medicines …

Zelboraf image

Roche’s melanoma pill launched in UK

March 14, 2012
Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf

Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer.  Zelboraf (vemurafenib) is the …

AstraZeneca picture

AstraZeneca sues FDA over generic Seroquel

March 14, 2012
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Seroquel, US, generics

AstraZeneca has said it filed a lawsuit against the US FDA in a bid to block approval of generic versions …

Pfizer picture

Pfizer pulls out of $350 million insulin pact

March 14, 2012
Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …

SHL talks about Autoinjector Development in Manufacturing Chemist’s latest issue

March 14, 2012
Manufacturing and Production auto injector, autoinjector, manufacturing chemist, pen injector, shl group

Manufacturing Chemist, an established publication in the biopharmaceutical industry, recently approached SHL to share with their readers the company’s knowledge …

Merck image

Merck warned over missing Januvia safety study

March 13, 2012
Research and Development FDA, Januvia, Merck, study

Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …

The Gateway to Local Adoption Series

Latest content